Tuberculosis Clinical Trials in Wuhan, Hubei
4 recruitingWuhan, Hubei, China
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc.532 enrolled33 locationsNCT07209761
Recruiting
Phase 2
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
TuberculosisMultidrug Resistant Pulmonary Tuberculosis
WestVac Biopharma Co., Ltd.60 enrolled7 locationsNCT07170800
Recruiting
Phase 3
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above
Tuberculosis
Chengdu CoenBiotech Co., Ltd1,784 enrolled8 locationsNCT07152639
Recruiting
Phase 4
The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)
Pulmonary Tuberculosis
Beijing Chest Hospital45 enrolled7 locationsNCT06476210